There are no items in your cart
Your generosity has enabled Mater Foundation Brisbane to provide more than $51 million in funding for projects across Mater Health, Mater Education and Mater Research—our world-class research institute—in the past three years alone.
Philanthropic support and gifts from donors and organisations are vital to the ongoing development of Mater. Please know that the many research developments and innovative new services available at Mater have only been made possible with your help.
It’s not about the size of your gift—we believe that anyone who gives to Mater, out of care for their community, is a very special person indeed.
Here are some of the ways your support has helped:
With the generous support of donors just like you, Mater has been able to introduce a number of innovative new services such as the Mater Young Adult Health Centre Brisbane (MYAHCB), which provides dedicated specialised services and environments for people predominately aged 16 to 25. MYAHCB provides programs for adolescents and young adults to address their emotional, social and educational needs as well as the management of chronic health conditions including diabetes and cystic fibrosis. Because of your support, patients can now recuperate and recover in an age-appropriate environment with access to Wi-Fi, free-to-air TV, indoor and outdoor social areas and a gym to help them on their health journey.
Also made possible with the support of donors, was the Mater Centre for Neurosciences which provides specialist care for epilepsy, neurosurgery, neurology and spinal surgery—a Queensland first—from one location. Philanthropic support helped fund both the centre and the state-of-the-art equipment needed to provide patients with the highest standard of clinical care, including two new Desktop EEG (electroencephalogram) Machines which record electrical activity in the brain and are essential for accurate diagnosis and treatment of seizure conditions. This equipment provides a non-invasive way for medical staff to determine why a patient is having seizures and prescribe the appropriate treatment to assist them in living a life free of seizures.
An extremely generous gift from the McEniery Family also led to the opening of a dedicated Stroke Unit as part of the Centre for Neurosciences, which means stroke sufferers and their families can now receive fast, and highly specialised, care during those terrifying moments when a stroke first sets in.
Please visit the Mater Health website to learn more.
In addition to a direct focus on patient care, philanthropic support has also made a direct impact towards enabling Mater’s simulation-based research to make a difference to the way neonatal babies are resuscitated at birth. Each year, 2000 Australian babies require advanced resuscitation and how well the resuscitation is done can affect whether the baby responds—it needs to be done with great skill to avoid damage to the baby’s fragile organs.
Thanks to your support, Mater’s Associate Professor Helen Liley led a clinical research and simulation project to improve the outcomes of babies who need to be resuscitated at birth and require subsequent neonatal intensive care. The results of this project have led to changes which have now been implemented at Mater and in hospitals nationwide.
Please visit the Mater Education website to learn more.
One of the major goals of cancer research has been to find an ‘anti-tumour vaccine’ which would enable a person’s immune system to kill cancer cells and eliminate them from the body. Thanks to the generous support of Mater supporters, donors and event participants, investment in Immunotherapy—a type of cancer treatment using a patient’s own specialised white blood cells (dendritic cells) to boost the body’s defence in the fight against cancer—has shown some effectiveness in early trials.
With ongoing philanthropic support, Associate Professor Kristen Radford and her team at Mater Research are now working towards developing a ‘next generation’ vaccination strategy which would offer a practical and affordable treatment approach for use in prostate cancer patients. This anti-tumour vaccine approach is considered a ‘therapeutic vaccine’ as it aims to treat cancer, rather than prevent it. If it is found to be successful, this approach could be used in other types of cancer.
Please visit the Mater Research website to learn more.
So thank you for your gift.
Thank you for doing your part to be a hero to thousands of people treated at Mater each year.
Baby Parker was rushed to NICU moments after birth.
Friendship lives on, even when those we love have gone.
Potential prostate cancer vaccine
Mater researchers have made a game-changing discovery.
Katherine was just 22 when her life changed in an instant.